IRCT201709049014N182已完成2 期
Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic stroke: a randomized clinical trial
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 85 years（—）
- 性别
- All
入选标准
- •Age of 18 to 85 years; acute ischemic stroke.
- •Exclusion criteria: A history of acute ischemic stroke in the past 3 months; using heparin or warfarin in the past 48 hours; a history of head trauma in the past 3 months; a history of intra cranial hemorrhage; a history of myocardial infarction in the past 3 months; gastric hemorrhage in the past 3 months; a history of major surgery in the past 2 weeks; a history of convulsion.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
t-PA trial for central retinal artery occlusioartery occlusionH341central retinal artery occlusionJPRN-jRCTs041190079Hayashi Atsushi20
招募中
3 期
The role of anticoagulant and thrombolitic in treatment of COVID patientsCOVID 19.COVID-19, virus identifiedU07.1IRCT20200515047456N1Tabriz University of Medical Sciences15
已完成
不适用
Recombinant tissue Plasminogen Activator administration by retinal branch vein route for Central Retinal Vein Occlusion: a randomised conventional therapy controlled trialCentral Retinal Vein Occlusion (CRVO)Eye DiseasesISRCTN58543190Oogziekenhuis Rotterdam (OZR) (The Netherlands)48
尚未招募
不适用
Tissue Plasminogen Activator levels in Diabetic footCTRI/2020/07/026277AIIMS Bhubaneswar
已完成
不适用
A study of plasminogen in subjects with spinal muscular atrophySpinal muscular atrophyNervous System DiseasesISRCTN21188633Talengen Institute of Life Sciences20